Document Detail


MCL-1 (myosin light chains-1) in differential diagnosis of dyspnea.
MedLine Citation:
PMID:  16170394     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myosin light chains-1 (MLC-1) have been recently associated with the markers of heart function (NYHA, LVEF, NT-proBNP). Verification of the relationship between markers of heart function (New York Heart Association classification (NYHA), left ventricle ejection fraction determination (LVEF), N terminal prohormone of natriuretic peptide B type BNP (NT-proBNP) and concentrations of myosin light chains-1 (MLC-1) was assessed. Patients examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction--LVEF) and in the serum of all subjects NT-proBNP (ELEIA) and MLC-1 (ELISA) were determined. In the 38 patients (21 men, 17 women), mean age of 58 years (+/-12 years as 1 SD), a significant negative correlation was found between NT-proBNP and LVEF (r = - 0.47; p = 0.02, Spearman). The median levels of NT pro-BNP were closely associated with NYHA classification (type II--584 ng/l, type III--2792 ng/l, type IV--6400 ng/l; p < 0.05). Individuals with clinical NYHA IV differed significantly in median MLC-1 concentrations from persons with clinical NYHA classification II and III (type II--5.7 ng/l, type III--8.9 ng/l, type IV--17 ng/l; p < 0.05). A significant negative correlation between MLC-1 and LVEF (-0.35; p < 0.03) and significant positive correlations between MLC-1 and NT-proBNP (0.42; p < 0.012) were found. In conclusion MLC-1 cannot be used as a diagnostic marker in differential diagnosis of dyspnea.
Authors:
David Stejskal; Borek Lacnák; Katerina Andelová; Marcela Skvarilová; Josef Bartek
Related Documents :
16170394 - Mcl-1 (myosin light chains-1) in differential diagnosis of dyspnea.
20147604 - Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.
21263364 - Lung aeration during ventilation after recruitment guided by tidal elimination of carbo...
1893644 - Control of blood pressure by the renin-angiotensin-aldosterone system.
10800824 - Cerebral vascular effects of aortovenous cannulations for pediatric cardiopulmonary byp...
7880134 - Contact media approach to burn scar management.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia     Volume:  149     ISSN:  1213-8118     ISO Abbreviation:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-09-19     Completed Date:  2006-06-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101140142     Medline TA:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub     Country:  Czech Republic    
Other Details:
Languages:  eng     Pagination:  89-91     Citation Subset:  IM    
Affiliation:
Department of Laboratory Medicine, Hospital Sternberk, Czech Republic. david.stejskal@quick.cz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Diagnosis, Differential
Dyspnea / etiology*
Female
Heart Failure / complications,  diagnosis*,  physiopathology
Humans
Male
Middle Aged
Myosin Light Chains / blood*
Natriuretic Peptide, Brain / blood
Peptide Fragments / blood
ROC Curve
Sensitivity and Specificity
Stroke Volume
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Myosin Light Chains; 0/Peptide Fragments; 0/myosin light chain I; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients wi...
Next Document:  High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: compariso...